Delivra Health Brands Inc.
DHBUF
$0.12
-$0.01-4.18%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -11.29% | 0.40% | 20.19% | -5.33% | 30.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.29% | 0.40% | 20.19% | -5.33% | 30.57% |
| Cost of Revenue | 0.48% | 7.95% | 14.19% | -5.33% | 50.01% |
| Gross Profit | -24.58% | -6.98% | 25.93% | -5.32% | 13.91% |
| SG&A Expenses | -11.59% | -11.71% | -15.85% | 1.69% | 24.17% |
| Depreciation & Amortization | -- | -91.80% | -11.75% | -6.04% | -2.80% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.88% | -10.41% | -2.01% | -2.39% | 30.34% |
| Operating Income | 30.16% | 94.63% | 254.01% | -47.97% | -29.40% |
| Income Before Tax | 49.18% | 81.14% | -67.47% | -40.54% | -21.61% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 49.18% | 81.14% | -67.47% | -40.54% | -21.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 49.18% | 81.14% | -67.47% | -40.54% | -21.61% |
| EBIT | 30.16% | 94.63% | 254.01% | -47.97% | -29.40% |
| EBITDA | -40.78% | 106.13% | 8,463.64% | -71.65% | -93.83% |
| EPS Basic | 49.46% | 82.05% | -60.00% | -40.30% | -3.33% |
| Normalized Basic EPS | 30.56% | 79.45% | 419.23% | -40.48% | 3.57% |
| EPS Diluted | 49.46% | 82.05% | -60.00% | -40.30% | -3.33% |
| Normalized Diluted EPS | 30.56% | 79.45% | 419.23% | -40.48% | 3.57% |
| Average Basic Shares Outstanding | 0.00% | 3.99% | -18.75% | 0.00% | 17.90% |
| Average Diluted Shares Outstanding | 0.00% | 3.99% | -18.75% | 0.00% | 17.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |